Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone vs Linagliptin on Bone Turnover Markers in T2DM
NCT02429232Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Oct 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02429232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02429232.